Livzon Group announced plans to spend 107 million yuan to acquire a 3.5044% stake in Xinbeijiang Pharmaceutical. On August 21, Livzon Group issued an announcement stating that the company signed a share transfer agreement with Zhuhai Zhonghuiyuan Investment Partnership and Xinbeijiang Pharmaceutical Co., Ltd., under which it intends to purchase the 3.5044% stake in Xinbeijiang Pharmaceutical held by Zhonghuiyuan. After the transaction is completed, Livzon Group will hold 90.6443% of Xinbeijiang Pharmaceutical, while Zhonghuiyuan will hold 4.9324%. Xinbeijiang Pharmaceutical is a controlling subsidiary of Livzon Group and will continue to be included in the company's consolidated financial statements. In the first half of 2026, Livzon Group achieved revenue of 5 billion yuan and net profit attributable to the parent company of 932 million yuan.
Livzon Pharmaceutical Group IncAcquiring additional stake in subsidiary increases control and consolidates ownership.
Minority stake transfer, company remains subsidiary; no direct impact.
Selling stake in Xinbeijiang, but impact on partnership not detailed.
